Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you're searching for a buy now pay later option on Mounjaro injections, the honest answer is this: as a prescription-only medicine, Mounjaro can only be legally supplied following a clinical assessment and a valid prescription issued by a registered prescriber. No legitimate UK pharmacy can list it like a consumer product with a BNPL checkout. What you can do is access Mounjaro privately through a GPhC-registered online pharmacy like nume, pay for your treatment at the point of order, and get started the same week. The question of cost is real and worth understanding properly, and we'll walk through it below.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Buy now pay later works by separating the purchase decision from payment. That model sits badly with prescription medicines, and for good reason. Mounjaro (tirzepatide) is a Prescription-Only Medicine regulated under the Human Medicines Regulations 2012. The law requires a valid prescription, issued by a qualified prescriber who has clinically assessed the patient, before any supply can happen. The dispensing and payment happen together, at the point a licensed pharmacy fulfils that prescription.
That means sellers offering Mounjaro through a BNPL service (with no clinical assessment in the loop) are operating outside the law. The MHRA has warned publicly about fake weight-loss injection pens sold online and via social media, and enforcement has escalated significantly. In one operation alone, around 20 million doses of illegally traded weight-loss medicines (roughly £45 million in street value) were seized, and a counterfeit tirzepatide manufacturing site was raided. Some fake pens have contained insulin. If you are researching Mounjaro buy now pay later options in the UK, understanding why that route sits outside the law is the most important starting point. You can report any suspect seller via the MHRA's Yellow Card scheme.
The GPhC register lets you check whether any online pharmacy is legitimately registered, use the GPhC's public register to verify nume's registration (number 9012878) or to check any other service before handing over personal or financial information.
For people who don't qualify for NHS Mounjaro, or who'd rather not wait, a private prescription through a GPhC-registered online pharmacy is the correct route. Here's how it works in practice at nume.
You complete a free online consultation, your medical history, current weight, any relevant conditions. A named prescriber reads it. Not a chatbot, not a scoring algorithm; a GPhC-registered Independent Prescriber reviews the clinical picture and decides whether treatment is appropriate. If it is, a prescription is issued and your order is prepared the same day. If you order before midday, your pen arrives the next working day via tracked DPD delivery. If payday lands on a Thursday, you can start the process that afternoon and have your treatment at the door by Friday.
Every repeat order goes through the same clinical re-review. There are no automatic renewals and no subscription. The team behind nume built the service around safety infrastructure: photo-ID verification, live weight confirmation on video call, GP notification in line with GPhC guidance, and Summary Care Record checks where appropriate. Our clinical team profile sets out who is overseeing your care.
For a broader look at how Mounjaro works and what the treatment involves, the Mounjaro treatment page covers the full picture.
Cost is the honest reason many people search for BNPL options, and it deserves a straight answer. Mounjaro is not cheap. Eli Lilly raised the UK list price from 1 September 2025, with the highest-dose pen rising from around £122 to around £330, and typical private prices since then have ranged roughly £149 to £375 per month depending on dose and provider, as widely reported. Those figures are worth knowing, even if they sting.
What varies between providers is what that price actually includes. Some headline figures exclude the consultation, the prescription fee, and delivery. A question our prescribers hear regularly is whether the low-headline-price option is actually lower once those extras are added. What goes into the cost of Mounjaro is worth reading before you compare. For a detailed breakdown of what each dose currently costs through private providers, the Mounjaro injection price page has more detail, including how prices have shifted since the Eli Lilly increase. For a detailed breakdown of what the entry-level dose currently costs through private providers, the Mounjaro injection 5mg price page has more detail.
At nume, one price covers everything: consultation, prescription, treatment, and next-working-day tracked delivery. We don't offer instalment arrangements or BNPL for the medicine itself. What we do offer is clarity about exactly what you're paying and what it includes, with no renewal you didn't choose. If the question is whether there's a cheaper route, this page on low-cost Mounjaro claims covers why the cheapest listing is rarely the right measure for a prescription medicine. Price is the wrong test; legitimate, clinically supervised supply through a verified pharmacy is the right one.
Mounjaro's UK licence covers adults with a BMI of 30 or above, or 27 or above with at least one weight-related condition such as high blood pressure, type 2 diabetes, high cholesterol, or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. Having a BMI that meets the threshold does not guarantee approval, the prescriber weighs the full clinical picture, including any contraindications. People who are pregnant, breastfeeding, or actively trying to conceive are not suitable for treatment, and Mounjaro is not licensed for under-18s.
The NHS has its own phased access criteria for Mounjaro, based on BMI and the number of qualifying conditions a patient has. Those criteria are strict and the rollout is gradual, our weight-loss overview explains both routes. Private treatment through a regulated pharmacy is open to people who meet the clinical criteria but either don't qualify for NHS supply yet or prefer not to wait. If you have any questions before starting, our FAQs page or our support team are both there. The NICE technology appraisal for tirzepatide (TA1026) sets out the clinical evidence base if you want to read the official guidance.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.